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Pregnane and Xenobiotic Receptor (PXR) is a transcription factor that is activated by a diverse range of xenobiotics and endogenous
metabolites including steroids, bile acids and about 50% of the prescription drugs. In specific cell types (e.g. liver and intestine) it serves as a
Fxenosensor_ by regulating expression of a network of genes involved in xenobiotic clearance from the body. PXR expression in several cancerous
tissues and its regulated expression of multi-drug resistance proteins highlight its significance in prognosis of malignancies. The view that
subcellular localization and ligand induced movements of transcription factors is one of the major phenomena in regulating transcriptional activity,
we used a green fluorescent protein tagged PXR chimera to study its dynamic behaviour in living cells. Under all experimental conditions, PXR
was observed to be a predominantly nuclear protein maintaining a dynamic equilibrium between the nuclear and cytoplasmic compartments of the
interphase cells. Interestingly, for the first time, a member of the nuclear receptor superfamily, PXR, has been observed to be associated with
condensed chromosomes during all the mitotic stages of cell division. The significance of PXR association with mitotic chromosomes is
discussed.
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Members of the nuclear receptor superfamily orchestrate a
diverse array of transcriptional responses to endogenous and
exogenous stimuli. The pregnane X receptor/steroid and
xenobiotic receptor (PXR/SXR)1 is a new member of the
steroid/nuclear receptor superfamily [1,2]. Like other nuclear
hormone receptors, it contains three distinct domains, an N-
terminal transactivation domain, a central DNA-binding
domain and a C-terminal ligand-binding domain and has been
shown to mediate the genomic effects of several steroids,
secondary bile acid derivatives, pharmacologic substances and
environmental contaminants [3,4]. In general, PXR appears to0167-4889/$ - see front matter D 2005 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamcr.2005.10.004
* Corresponding author. Fax: +91 11 2616 1781.
E-mail address: rkt2300@mail.jnu.ac.in (R.K. Tyagi).
1 The protein has been termed either PXR or SXR in different reports. In the
interest of simplicity the term PXR is being used to represent the two names of
the same protein.have evolved to interact and regulate metabolism of structurally
diverse compounds by coordinating and regulating the expres-
sion of a network of genes that control xenobiotic clearance
from the liver and intestine. Among the critical target genes it
regulates are those involved in phase I, phase II and phase III
metabolism of xenobiotics [5]. In phase I, the major reaction
involved is hydroxylation, catalysed by a class of enzymes
referred to as monooxygenases or cytochrome P-450s (CYP).
Members of CYP3A sub-family (mainly CYP3A4) is respon-
sible for metabolizing more than 50% of all drugs, and its
inducible expression through PXR activation is reported to play
a pivotal role in the clearance of a number of endogenous as
well as exogenous xenobiotic compounds [6–10]. In phase II,
the phase I derivatives are converted to various polar
metabolites by specific enzyme-mediated conjugation with
glucuronic acid, sulfate, acetate, glutathione or by methylation.
During phase III metabolism, the resultant water-soluble
(polar) compounds are eliminated from the cellular milieu
[5]. Furthermore, xenobiotics induced transcriptional activityta 1746 (2005) 85 – 94
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and a variety of biological effects with pharmacological,
toxicological and immunological consequences [11,12].
The detection of PXR in cancerous tissues and its regulated
expression of multidrug resistance proteins highlight its
significance in malignancies and warrants further investigation
into molecular details involved [13–17]. Subcellular localiza-
tion and dynamic movement of transcription factors have been
shown to be one of the major means of regulating transcrip-
tional activity. In this perspective, the present study documents
that PXR is predominantly a nuclear protein maintaining a
dynamic equilibrium between the nuclear and cytoplasmic
compartments. In addition to its predominantly nuclear
residency, PXR has been observed to be associated with
condensed chromosomes during mitosis that may have
physiological implication in its function as a transcription
factor, acting as a Fxenosensor_ for diverse range of endoge-
nous and exogenous compounds.
2. Materials and methods
2.1. Reagents and biochemicals
Restriction endonucleases and ligase were obtained from New England
Biolabs (Beverly, MA, USA). Dulbecco’s Modified Eagle’s Medium (DMEM),
fetal bovine serum (FBS), dextran-charcoal stripped serum and other
mammalian cell culture reagents were procured from Hyclone (Logan, Utah,
USA). Lipofectaminei 2000 was procured from Invitrogen Corporation
(Carlsbad, CA, USA). All plastic-wares for mammalian cell culture were
purchased from Corning Costar Corp. (Corning, NY, USA). HRP-conjugated
anti-rabbit secondary antibodies raised in goat were from Bio-Rad (Hercules,
CA, USA). Protein concentrations were determined using CB-X protein assay
kit (Genotechnology, MO, St. Louis, USA). All other chemicals (unless
otherwise mentioned) were obtained from Sigma Chemicals Co. (St. Louis,
MO, USA).
2.2. Plasmids
Mammalian expression vectors for human PXR, pSG5-hPXR, and a
promoter– reporter gene, XREM-CYP3A4-Luc were kindly provided by Dr.
S.A. Kliewer (University of Texas, Southwestern Medical Center, Dallas,
USA) and Dr. C. Liddle (University of Sydney at Westmead Hospital,
Australia), respectively. Expression vector for mouse cytoplasmic constitutive
active/androstane receptor retention protein (pcDNA-CCRP) was a generous
gift from Dr. M. Negishi (National Institute of Health, North Carolina,
USA). GFP tagged human androgen receptor (GFP-AR) and glucocorticoid
receptor (GFP-GR) were gift from Prof. O.A. Janne (University of Helsinki,
Finland) and Dr. M. D. Galigniana (University of Michigan Medical School,
USA), respectively. We cloned the full-length cDNA for hPXR between
EcoRI and BamHI restriction sites of pGFP-C2 (Clonetech) and designated
it as GFP-PXR. In the text untagged human PXR is referred as WT-PXR.
The plasmid pcDNA-CCRP encodes CCRP as a fusion chimera to His-tag at
its carboxy-terminal.
2.3. Maintenance of cell lines and transient transfections
Cell lines used in this study were COS-1 (kidney cell line from African
green monkey), HepG2 (human liver cell line) and NIH-3T3 (mouse embryo
fibroblast cell line). These ATCC cell lines were obtained from National Centre
for Cell Science repository (Pune, India). COS-1 and HepG2 cells were grown
in DMEM supplemented with 10% FBS, 100 Ag/ml penicillin and 100 Ag/ml
streptomycin (complete medium), while NIH-3T3 cells were grown in DMEM
supplemented with 10% cosmic calf serum, 100 Ag/ml penicillin and 100 Ag/ml
streptomycin, according to ATCC recommendation. The cultures weremaintained in a humidified incubator maintained at 5% CO2 and 95% air
atmosphere at 37 -C.
Transient DNA transfections in COS-1, HepG2 and NIH-3T3 cells were
performed using Lipofectaminei 2000 or Escort reagents according to the
instruction provided by the manufacturers.
2.4. Luciferase reporter gene assays
HepG2 cells were seeded into 6-well plate and transfected with 500 ng of
XREM-CYP3A4-Luc promoter– reporter plasmid and 50 ng of WT-PXR or 50
ng of GFP-PXR or carrier DNA, according to the manufacturer’s protocol.
Following the transfection period, cells were supplemented with 5% steroid
stripped medium and treated with 10 AM rifampicin or DMSO (vehicle) and
further incubated at 37 -C for 24 h. To determine the reporter gene activity,
cells were harvested and luciferase assays were performed according to the kit
protocol (Promega, Madison, WI, USA).
2.5. Generation of HepG2-PXR cell line stably expressing human PXR
HepG2 cells were transfected with WT-PXR expression plasmid and a
vector that contains neomycin resistance gene (pcDNA3) in 10:1 molar ratio
and were allowed to double once under non-selective conditions. Later, cells
were supplemented with the complete medium containing 400 Ag/ml of G418
(selective medium) and the medium was replaced every third day. After 2
weeks of selection period, individual colonies were isolated and further
propagated under selective conditions. Individual clones were screened for the
stable expression of PXR by indirect immunodetection and Western blotting
analysis using PXR specific polyclonal antibodies. These antibodies have been
raised in rabbit against the full-length PXR protein that was purified utilizing
bacterial expression system [18].
2.6. Fluorescence imaging
2.6.1. Live cell imaging
Cells cultured on glass cover slips in 35-mm dishes were transfected
with 500 ng of either of the following plasmids, GFP, GFP-PXR, GFP-AR
or GFP-GR, according to the manufacturer’s protocol. Wherever appropri-
ate, a combination of 100 ng of GFP-PXR and 100–500 ng of CCRP
expression plasmids were used. Following the transfection period, the cells
were supplemented with fresh DMEM containing 5% charcoal-stripped or
FBS or serum replacement medium (Sigma) and incubated further for 24 h.
Cells transfected with GFP-GR or GFP-AR were treated either with 108 M
dexamethasone (DEX) or 108 M dihydrotestosterone (DHT), respectively,
3 h prior to fluorescence microscopy. To facilitate the visualization of the
nucleus, Hoechst was added to the live cells at least one h prior to imaging.
For quantitation, subcellular localization of the GFP-PXR was scored in at
least 100 live COS-1 cells. Localization was considered as nuclear (N)
when fluorescence was exclusively in the nucleus and absent in the
cytoplasm. It was considered predominantly nuclear (N>C) when fluores-
cence was stronger in the nucleus than in the cytoplasm. When the
fluorescence was uniformly divided between the nuclear and cytoplasmic
compartment it was designated C=N.
2.6.2. Immunocytochemistry
For indirect immunodetection, cells were cultured on glass cover slips and
transfected with 500 ng of WT-PXR expression plasmid and were cultured for
24 h following transfection. Wherever appropriate, a combination of 100 ng of
WT-PXR and (or) 100–500 ng of CCRP expression plasmids were used. Cells
from HepG2–PXR stable cell line were directly cultured over sterile glass
cover slips. The cells were washed thrice with 10 mM phosphate-buffered
saline (PBS) and then fixed with chilled methanol (20 -C) for 15 min on ice.
Following fixation, the cover slips were washed with PBS, air dried and kept at
20 -C for 1 h. The cells were then equilibrated in a humidified chamber for 30
min and blocked in 1% bovine serum albumin (BSA) in PBS for 30 min. The
cells were then incubated either with PXR polyclonal antiserum at a dilution of
1:1000 or anti-His antibodies at a dilution of 1:500 at 4 -C for 12–16 h.
Following washes with PBS, the cells were further incubated with Cy3-
Fig. 1. Comparative analysis of GFP-PXR transcriptional activity with WT-
PXR. HepG2 cells were co-transfected with XREM-CYP3A4-luciferase
reporter plasmid and different combinations of WT-PXR expression plasmid,
GFP-PXR and carrier DNA according to the scheme shown in the figure.
Following the transfection period, cells were supplemented with 5% steroid
stripped medium and treated with 10AM rifampicin or DMSO (vehicle). After
24 h of expression period, cells were harvested and luciferase assays were
carried out as described under Materials and methods. Transcriptional activity
of WT-PXR represented as 100% is compared with that of GFP-PXR. The
results are means (TS.D.) of three independent determinations. Rif, represents
the ligand rifampicin.
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were mounted and visualized under the fluorescence microscope. Hoechst
33342 was co-incubated with the secondary antibody to facilitate the
visualization of the nucleus. The fluorescent cells were viewed through a
Nikon upright fluorescence microscope model 80i equipped with water
immersion objectives and connected to cooled CCD digital camera (model
Evolution VF, Media cybernatics, USA). Images were captured and analysed
with Image ProPlus version 5.0 software (Media cybernatics, USA). The
images were processed using standard image processing techniques.
2.7. Western blot analysis
COS-1 cells were transiently transfected with 500 ng of WT-PXR
expression plasmid and allowed to express the protein for 20 h. Following
transfection period, the cells were lysed directly in SDS-PAGE sample buffer
and used for Western blotting. Untransfected COS-1 cells, HepG2 cells and
cells from HepG2-PXR stable cell line were also lysed similarly. Prior to
Western blotting, all the extracted samples were denatured by heating at 95 -C
for 3 min. Equal amount of proteins from PXR expressing cells and
corresponding normal (control) cells were resolved by 10% SDS-PAGE.
Proteins were transferred to polyvinyldifluoridine (PVDF) membrane using
semi-dry transfer system (BioRad). After the transfer, the blot was stained with
Ponceau S to confirm the efficiency and uniformity of protein transfer.
Following transfer, the membrane was blocked with 5% non-fat milk powder
(dissolved in TBS) for 2 h at room temperature and then incubated with PXR
antiserum or preimmune serum (control) at a dilution of 1:5000 over night at 4
-C. The PVDF membrane was then washed three times with TBST (TBS with
0.1% Tween-20) and incubated for 1 h with 1:10,000 dilution of horseradish
peroxidase-conjugated anti-rabbit secondary antibody (Sigma). The bound
antibody complexes were detected using the enhanced chemiluminescence
(ECL) system.
2.8. Heterokaryon assay
Interspecies heterokaryon assays have been used in the study of
nucleocytoplasmic shuttling of nuclear hormone receptors and were performed
as described previously [19]. Briefly, COS-1 cells were transfected with 500 ng
of GFP-PXR using Lipofectaminei 2000 according to manufacturer’s
protocol. After 24 h, the COS-1 cells were rinsed with PBS, trypsinized and
mixed with equal number of NIH-3T3 cells and seeded onto the glass cover-
slips. Once the cells adhered to the substratum in close proximity to each other,
they were suitable for heterokaryon formation. Thirty minutes prior to Cell
fusion, cycloheximide (50 Ag/ml medium) was added to the culture medium to
prevent de novo synthesis of proteins. Cells were fused by layering a fine film
of polyethylene glycol (PEG) for 2 min followed by extensive washing to
remove PEG. The cells were then supplemented with 5% steroid stripped
medium containing cycloheximide and Hoechst to facilitate the visualization of
the nucleus and incubated in the CO2 incubator. Wherever appropriate,
rifampicin was included in the medium to 10 AM concentration. The cells
were observed under fluorescence microscope to assess the fusion efficiency
and receptor localization.
3. Results
3.1. Preparation of a transcriptionally active GFP tagged
human PXR for live cell imaging
In recent years, expressing the proteins as a fusion partner to
the fluorescent proteins (like GFP and its colour variants) has
emerged as a vital tool for studying the virtual residency of
proteins in subcellular compartment(s) of living cells. Howev-
er, in certain instances, tagged transcription factors may
produce a fusion protein that is transcriptionally inactive
rendering its use somewhat controversial. Hence, to substan-
tiate the functional behaviour of our chimeric GFP-PXR, wedetermined its transcriptional competence and compared with
the untagged PXR (WT-PXR) by using promoter–reporter
gene assays. Firstly, we co-transfected HepG2 cells with WT-
PXR construct along with XREM-CYP3A4-Luc to determine
the plasmid ratio required for its optimal transcriptional
activity. Our results indicated that 50 ng of WT-PXR construct
co-transfected with ten-fold excess of promoter–reporter
plasmid gives the best transcriptional response with 10 AM
rifampicin. In comparison to WT-PXR induced luciferase
activity (100%), GFP-PXR chimera was observed to retain
up to 60% of the transcriptional activity (Fig. 1). These results
ascertained that GFP-PXR chimera has retained a substantial
level of transcription function and therefore could be used in
further studies related to receptor function and dynamics when
expressed in cultured cells.
3.2. Subcellular distribution of GFP-PXR in COS-1 and
HepG2 cells
For examining the subcellular localization of PXR in live
cells, COS-1 and HepG2 cells were transiently transfected with
GFP-PXR chimera and the receptor was allowed to express
under normal culture conditions. Our results from live cell
imaging revealed that in majority of the cells, PXR was present
in the nuclear compartment and was excluded from the
nucleolus (Fig. 2A). After studying the localization profile
under normal cell culture conditions, the GFP-PXR was also
expressed in steroid, antibiotic and serum-free, as well as, in
conditions where serum replacement reagent (Sigma) was used.
Under all these variations in culture conditions, PXR did not
exhibit any significant transcriptional activity that could be
attributed to its activity over the background response in
Fig. 2. (A) Subcellular localization of GFP-tagged PXR fusion protein in COS-
1 and HepG2 cells. Cells were transiently transfected with GFP-PXR and 24
h after the expression period, fluorescent cells were imaged as described under
Materials and methods. In control experiments, GFP expression vector was
transfected in COS-1 cells. To facilitate the visualization of the nucleus Hoechst
was added to the live cells at least one h prior to imaging. (B) Subcellular
localization of GFP-GR and GFP-AR in COS-1 cells. COS-1 cells were
transiently transfected with GFP-GR or GFP-AR expression plasmids and
allowed to express the fusion proteins for 24 h under steroid-free conditions.
After the expression period, cells were treated either with 108 M
dexamethasone (DEX) (top right) or 108 M dihydrotestosterone (DHT)
(bottom right) or vehicle (control) (left panel) for 3 h and the fluorescent cells
were imaged as described under Materials and methods. To facilitate the
visualization of the nucleus Hoechst was added to the live cells at least one
h prior to imaging. (C) Quantitative data for subcellular localization of the
GFP-PXR in COS-1 cells. The percentages of cells expressing PXR were
categorized into exclusively nuclear (N), predominantly nuclear with marginal
fluorescence in cytoplasm (N>C) or uniformly distributed between nuclear and
cytoplasmic compartment (C=N). The results represented are means (TS.D.) of
three independent determinations.
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PXR was apparently unliganded but still observed to be
localized predominantly in the nuclei. Conversely, under
similar ligand-free conditions GFP tagged androgen and
glucocorticoid receptors are observed to be localized in the
cytoplasm (Fig. 2B), indicating that the culture conditions were
essentially at least steroid free and that over-expression of these
receptors did not appear to alter their subcellular localization.
Quantitation for localization of GFP-PXR in live cells is shown
in Fig. 2C. In about 80% of the cells, the receptor was observed
to be localized exclusively in the nuclear compartment. In
about 15% of the cells, PXR localized predominantly in the
nucleus and partly in the cytoplasm. A small population of cells
(¨5%) showed receptor uniformly distributed between the
nuclear and cytoplasmic compartment.
3.3. Localization of untagged PXR in transiently and stably
transfected cells
After studying the localization of GFP-PXR chimera, we
further confirmed the localization of PXR where untagged WT-
PXR was used for receptor expression. This approach was
undertaken essentially for the reason that the 27 kDa GFP tag
fused to 50 kDa PXR protein may alter the receptor localization
profile. For this purpose, a polyclonal antibody recently raised
in our laboratory against the full-length PXR protein was used.
In Western blot, using transiently and stably transfected cells,
this antibody specifically recognizes a 50-kDa band corres-
ponding to PXR (Fig. 3A). Using this antibody the subcellular
localization of untagged PXR was confirmed in transiently
transfected COS-1 and stably transfected HepG2 cells by
indirect immunodetection. Since the endogenous levels of PXR
in HepG2 cells were undetectable by indirect immunodetec-
tion, we prepared a stably transfected cell line in HepG2 that
expressed PXR constitutively. Furthermore, studies with stably
transfected cell line expressing PXR are preferred since
potential artefacts due to over expression of a protein in
transient transfections can be eliminated. Immunodetection
results for receptor localization in transient and stably
transfected cells are shown in Fig. 3B–D. We observed that
receptor localization results from untagged PXR in fixed cells
were in agreement with GFP-tagged PXR localization in living
cells.
3.4. CCRP does not alter subcellular localization of human
PXR
Mouse PXR has recently been shown to be maintained in
the cytosol in complex with the endogenous Fcytoplasmic CAR
retention protein_ (CCRP) [20]. Hence, we also investigated the
role of CCRP in modulating the localization of human PXR.
For this, COS-1 cells were transiently co-transfected with WT-
PXR and with increasing ratio of CCRP expression plasmid.
Using indirect immunodetection and specific PXR antibodies
we monitored for any shift in the localization of expressed
receptor that may be attributed to the presence of CCRP. Our
results from co-transfection of untagged PXR and CCRP in
Fig. 3. (A) Western blot analysis of the PXR in transiently transfected COS-1 cells and HepG2–PXR stable cell line. Whole cell extract from untransfected COS-1
and HepG2 cells (controls) and from transiently transfected COS-1 cells and HepG2-PXR stable cell line were prepared and electrophoresed through 10% SDS-
PAGE. Proteins were transferred on to the PVDF membrane and probed with anti-PXR antibodies (lanes 1–4) or pre-immune serum (lanes 5–8) at a 1:5000
dilution. Lane 1, Untransfected COS-1 cells extract, no band was detected; Lane 2, PXR transfected COS-1 cells extract, a band of relative molecular weight 50 kDa
was detected; Lane 3, normal HepG2 cell extract, no band was detected; Lane 4, HepG2-PXR stable cell line extract, a band of relative molecular weight 50 kDa was
detected. No bands were detected with preimmune serum. (B) Subcellular localization of untagged full-length PXR transiently expressed in COS-1 cells. Cells were
transfected with WT-PXR and after 24 h of expression, cells were fixed, processed for immunodetection with anti-PXR antibodies (a and b) or preimmune serum (c
and d) at dilution of 1:1000 and imaged as described under Materials and methods. The left panel shows the distribution pattern of receptor in immunodetected cells.
The right panel shows the Hoechst staining for visualizing the nuclei. (C) Subcellular localization of PXR in HepG2-PXR stable cell line. Cells were fixed, processed
for immunodetection with anti-PXR antibodies (a and b) or preimmune serum (c and d) at dilution of 1:1000 and imaged as described under Materials and methods.
The left panel shows the distribution pattern of receptor in immunodetected cells. The right panel shows the Hoechst staining for visualizing the nuclei. (D)
Subcellular localization of PXR in HepG2-PXR stable cell line under ligand free (without rifampicin) and in presence of ligand rifampicin. Cells from HepG2-PXR
stable cell line were cultured either in absence of rifampicin (a and b) or in presence of rifampicin (c and d) and processed for immunodetection with anti-PXR
antibodies at a dilution of 1:1000 and imaged as described under Materials and methods. The left panel shows the distribution pattern of PXR in immunodetected
cells. The right panel shows the Hoechst staining for visualizing the nuclei. Rif, represents the ligand rifampicin.
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localization of PXR (Fig. 4A). In addition, co-transfection of
fusion chimera, GFP-PXR and CCRP in COS-1 cells at 1:5
ratio showed clear nuclear localization of GFP-PXR (Fig. 4B).
Similar results were obtained in HepG2 and NIH-3T3 cells
(data not shown). Therefore, we conclude that even in the
presence of high CCRP expression, the localization pattern of
PXR remains unaltered.
3.5. PXR associates with condensed chromosomes during
mitotic stages
During the course of our subcellular localization studies for
PXR, we made an unanticipated observation in the cells that
were transfected with GFP-PXR and undergoing mitosis. In
these dividing cells, we observed the localization of GFP-PXRalong with the Hoechst-stained mitotic chromosomes that
prompted us to undertake this study in a systematic manner.
For this purpose, GFP-PXRwas expressed in COS-1 cells and its
dynamic localization during interphase and mitotic stages was
studied. We observed that in COS-1 cells, GFP-PXR protein
remained bound to the mitotic chromosomes through all the
stages of mitosis (Fig. 5A). Similar results were observed in
GFP-PXR transfected hepatocytes (HepG2), the cells where
endogenous PXR is reported to be primarily expressed (data not
shown). In control experiments, GFP alone expressed under
similar conditions did not show any such chromatin-labelling
pattern. The expressed GFP was homogenously distributed and
was distinctly excluded from the area bearing the mitotic
chromosomes (Fig. 5B). It is important to mention here that
this phenomenon has been observed in living cells dividing
naturally, i.e., without imparting any chemical arrest.
Fig. 4. (A) Subcellular localization of PXR in COS-1 cells when co-expressed with CCRP. Cells were transiently transfected with CCRP expression plasmid alone
(row a) or in combination with PXR (row b and c). After 24 h of expression period, cells were fixed, processed for immunodetection with anti-His antibodies (row a
and b) or anti-PXR antibodies (row c) and imaged as described under Materials and methods. The left panel shows the distribution pattern of receptor in
immunodetected cells. The middle panel shows the Hoechst staining for visualizing the nuclei. The right panel shows the overlay images for both the fluorescence.
(B) Subcellular localization of GFP-PXR in live COS-1 cells when co-expressed with CCRP. Cells were transiently co-transfected with GFP-PXR and CCRP and 24
h after the expression period, fluorescent cells were viewed as described under Materials and methods. To facilitate the visualization of the nucleus Hoechst was
added to the live cells at least 1 h prior to imaging.
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iour of untagged PXR in COS-1 and HepG2 cells by
immunodetecting the transfected PXR. However, our attempt
to acquire a similar mitotic profile with transiently
transfected fixed cells was difficult apparently for the reason
that dividing cells attain a spherical morphology and are
loosely attached to the substratum. So, cell fixation and
immunodetection procedure are severe enough for these
loosely adhered transfected cells leading to their loss from
the substratum. Similar failures were also evident in an
earlier report with TBP where mitotic cells images could be
found only with live cells expressing GFP-tagged chimera
and not with transiently transfected fixed cells used for
immunodetection [21]. To overcome this problem and
increase the prospect of finding diving cells without the
requirement of transfection, we used the HepG2-PXR stable
cell line where all the cells are expressing PXR thereby
improving chances of finding some remanent cells in mitotic
stages. The results showing behaviour of PXR during
interphase and different stages of mitosis obtained by this
approach are represented in Fig. 5C. It is evident that
results from fixed cells using untagged PXR were in
accordance with observations made in living cells expressing
transiently transfected GFP-PXR.3.6. Nucleocytoplasmic trafficking of GFP-PXR in
heterokaryons
Some of the members of the nuclear receptor superfamily
have been known to shuttle between nucleus and cytoplasm.
Hence, we investigated the nucleocytoplasmic shuttling nature
of GFP-PXR by interspecies heterokaryon assay as described
previously [19]. Briefly, COS-1 cells were transiently trans-
fected with 500 ng of GFP-PXR and allowed to express the
protein. These cells were further co-cultured with mouse NIH-
3T3 cells and fused to form heterokaryons using polyethylene
glycol (PEG). Thirty minutes prior to cell fusion, cyclohexi-
mide (50 Ag/ml medium) was supplemented in the culture
medium to prevent de novo synthesis of proteins. Following
PEG treatment, the cells were incubated in 5% steroid stripped
medium supplemented with cycloheximide and Hoechst. After
one h of fusion, the cells were analysed under fluorescence
microscope. NIH-3T3 nucleus could be distinguished from the
COS-1 nucleus by observing the presence of fluorescent sate-
llite bodies in Hoechst stained nuclei [19]. We observed that 4
h after cell fusion, the GFP-PXR translocated from COS-1
(donor) to NIH-3T3 (recipient) nuclei of all the heterokaryons
observed. This indicated that there is a reversible association of
GFP-PXR with the chromatin and that the receptor was
. 5. (A and B) GFP-PXR associates with the condensed chromosomes during different stages of mitosis. COS-1 cells were transiently transfected with GFP-PXR lasmid (A) or GFP expression vector alone (B) as
cribed under Materials and methods. After 30 h of expression, dynamic movement of GFP-PXR or GFP during different mitotic stages were monitored and re rded by fluorescence microscopy. In all the cases,
ls were incubated with Hoechst to visualize the corresponding nuclei or mitotic chromosomes. (C) Untagged PXR associates with the condensed chromosomes ring all the stages of mitosis. Cells from HepG2–
R stable cell line were fixed, processed for immunodetection with anti-PXR antibodies at dilution of 1:1000 and behaviour of PXR during different mitotic s es were recorded by fluorescence microscopy as
cribed under Materials and methods. In figures A–C, the left panel show the distribution pattern of receptor in live or immunodetected cells. The middle panel s ws the Hoechst staining for visualizing the nuclei.
e right panel shows the overlay images for both the fluorescence.
M
.
S
a
ra
d
h
i
et
a
l.
/
B
io
ch
im
ica
et
B
io
p
h
ysica
A
cta
1
7
4
6
(2
0
0
5
)
8
5
–
9
4
9
1Fig
des
cel
PX
des
Thp
co
du
tag
ho
Fig. 6. Internuclear shuttling of GFP-PXR in live heterokaryons. COS-1 cells were transiently transfected with GFP-PXR expression vector and allowed to express
the protein for 24 h. Following protein expression, the cells were rinsed with PBS, trypsinized, mixed with equal number of mouse cell line NIH-3T3 cells and
seeded onto sterile glass coverslips. The co-cultured cells were then fused with polyethylene glycol (PEG) to generate heterokaryons (bottom panel) as described
under Materials and methods. After 4 h of cell fusion, the cells were directly observed by fluorescence microscopy. To prevent de novo protein synthesis,
cycloheximide (50 Ag/ml) was added to the culture media 30 min prior to fusion. The mouse nucleus could be identified by the presence of typical Hoechst
fluorescence of satellite bodies. The GFP-PXR was observed to be undergoing nucleocytoplasmic trafficking in heterokaryon as revealed by its movement from
COS-1 (donor, c) to mouse NIH-3T3 (recipient, m) nucleus. In control (unfused cells) GFP-PXR florescence is visible only in COS-1 cells and not in unfused NIH-
3T3 cells. The left panel shows the distribution pattern of receptor in live cells/heterokaryons. The middle panel shows the Hoechst staining for visualizing the nuclei.
The right panel shows the overlay images for both the fluorescence.
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This nucleocytoplasmic shuttling of PXR was evident even in
the presence of PXR ligand rifampicin and appeared to be
reduced only marginally (not shown). However, since hetero-
karyons can be formed and visualized only between interphase
cells, these observations are true exclusively for interphase
cells and this conclusion cannot have any bearing to stress if
PXR during mitosis is bound to chromatin reversibly or
irreversibly.
4. Discussion
The subcellular localization of unliganded members of the
nuclear hormone receptor family can be classified into two
distinct groups, one that requires ligand binding for cytoplas-
mic-to-nuclear translocation (e.g., androgen, glucocorticoid
and mineralocorticoid receptors) and the other that is nuclear,
even in the absence of ligand binding (e.g., estrogen and
progesterone receptors) [22–24]. Presently, the data available
on the dynamic behaviour and subcellular localization of PXR
is not well established. From the experiments based on cultured
mammalian cells and histological studies, PXR has been
previously reported to be localized either in the nucleus or in
the cytoplasm [25]. In that study, for receptor localization, the
purified GFP-tagged truncated variants of PXR were either
microinjected in cultured cells or immunodetected in fixed cells
and tissue sections. In another recent report, YFP tagged mouse
PXR was shown to be retained in the cytoplasm of mouse liver
cells that translocated into nuclei with ligand, PCN [20]. In our
attempts, using fluorescence microscopy to visualize the GFP-
tagged PXR, we observed that the receptor predominantly
localized in the nucleus of COS-1 and HepG2 cells, both, in the
absence and presence of potential ligands, including rifampi-cin. PXR has been shown to posses a diverse ligand preference
[26]. Hence, one can speculate that even under in vivo
situations, localization of PXR should be nuclear due to
circulating endogenous ligands and steroids. Under ex vivo
conditions, medium used for mammalian cell culture is
supplemented with a number of life supporting ingredients
including vitamins, amino acids and other essential compo-
nents. In our attempts to study subcellular localization of
unliganded PXR, we used a number of cell culture conditions
to prevent PXR-ligand interactions. In addition to steroid-free
culture conditions, we also expressed PXR in cells under
serum-free, antibiotic-free and serum replacement conditions.
These conditions provided situation where PXR was essentially
transcriptionally inactive implying that receptor is ligand-free.
To preclude the over-expression as a plausible reason for ligand
independent nuclear localization, we expressed GFP-PXR with
reasonably low quantity of plasmid. Further, we expressed
PXR as untagged protein in COS-1 cells and also generated a
stable cell line (HepG2–PXR) expressing the receptor and
immunodetected using PXR specific antibodies. We also
cultured the cells from HepG2–PXR cell line under ligand-
free conditions as well as with addition of ligand rifampicin in
the culture medium. Under all possible variations in cell culture
conditions and expression modalities, PXR was always
observed to be a predominantly nuclear protein. Whether any
of the PXR ligands is still present in basic cell culture media
could not be totally ruled out. Therefore, with some caution, we
concluded that unliganded PXR is a nuclear protein similar to
unliganded ER and PR. This is in accordance with the finding
by other group where microinjected PXR was shown to
translocate and reside in the nucleus of HeLa cells [25].
However, the discrepancy regarding PXR localization in the
cytoplasmic compartment in fixed tissue sections is somewhat
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conditions.
Negishi and co-workers have shown that mouse PXR
(NR1I2) and another closely related nuclear receptor, consti-
tutive active/androstane receptor (CAR, NR1I3) sequestered in
the cytoplasm of untreated liver cells by forming a complex
with CCRP and translocated into the nucleus in response to
ligand treatment [20,27]. Hence, we also investigated the
involvement of CCRP in influencing the localization profile of
human PXR in cultured cells. Our results obtained from
fluorescence microscopy of living or fixed COS-1, HepG2 and
NIH-3T3 cells revealed no alteration in the localization pattern
of PXR even in the presence of moderate to high CCRP levels.
The discrepancies between our findings and earlier reports
could be due to the differences between human PXR and
mouse PXR and/or differing experimental models. On the
contrary, our observation made with a liver cell line stably
expressing Funtagged_ PXR can be considered a concrete
evidence to reflect an ideal in-vivo situation thereby providing
a strong evidence in support of PXR localization.
The finding that a nuclear receptor, PXR binds to condensed
chromosomes during all the stages of mitosis is novel and was
unanticipated. In general, with the onset of mitosis, the active
gene transcription in interphase nuclei of eukaryotic cells is
silenced [28]. Until recently, this repression was believed to be
imposed solely from the condensation of interphase chromatin
into mitotic chromosomes. However, recent studies have
shown that changes in chromatin structure and occupancy of
promoter elements by both general and gene-specific tran-
scription factors also play a role in transcriptional silencing.
The molecular details of mechanisms utilized by transcription
factors to repress transcription are beginning to be elucidated
[29]. Studies with simplified systems revealed that reversible
phosphorylation of the basal transcriptional machinery and
core histones by cyclin-dependent kinase or its downstream
kinases repress transcription during mitosis by dislodging
protein complexes. However, there are evidences indicating
that some proteins remain associated to condensed chromatin
during mitosis e.g. TATA binding proteins (TBP), selectivity
factor 1 (SL1), upstream binding factor (UBF), RNA poly-
merase I, activator protein 2 (AP-2), serum response factor
(p67-SRF), heat shock transcription factor 1 (HSF1) and high
mobility-group protein A1a (HMGA1a) ([21,29,30] and
references therein). In this context, we report for the first time,
the binding of a nuclear receptor family member, PXR, to
condensed chromosomes throughout mitotic stages. To exclude
the possibilities arising from non-specific binding of green
fluorescent protein, we conducted cross-confirmatory control
experiments with GFP alone. Our observations indicated that
unlike GFP, GFP-PXR binding to mitotic chromosomes was
specific to this receptor. Similar profile from HepG2-PXR cell
line stably expressing untagged PXR further strengthened our
observations in living cells expressing transiently transfected
GFP-PXR.
Nuclear hormone receptors are known to continuously
shuttle between the nuclear and cytoplasmic compartments
[31]. To examine if our construct GFP-PXR is binding to DNAreversibly or irreversibly, we performed the nucleocytoplasmic
shuttling studies and proved the existence of reversible
association of GFP-PXR to interphase DNA. However, such
an association of PXR with the mitotic chromosomes may be a
preparatory step towards setting a stage for regulating the
transcriptional events to meet the immediate needs of newly
divided cells. Once the cells exit from mitosis, some of the
PXR co-regulated genes might be subjected to earliest onset of
regulation and eventually assist the cellular machinery to
overcome the external stress and environmental damages to
which the newly divided cells are vulnerable. Additionally,
whether PXR binding to mitotic chromosomes has a role in
assisting chromatin condensation and chromosomal segrega-
tion or in preventing damaging events to genome is presently a
matter of speculation. However, future studies will be expected
to reveal significance of this behaviour.
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